INN: Ethyl methyl hydroxypyridine succinate
Presentation: film-coated tablets, 125 mg No.50
The product is on the list of Vital and Essential Drugs. Registration number: PL-006028
Prescription drug
Pharmacotherapeutic group: antioxidant agent
Indications for Use:
- consequences of acute cerebrovascular, including after transitory ischaemic attacks in the subcompensation phase as preventive courses;
- mild traumatic brain injury (TBI), TBI consequences;
- encephalopathy of different genesis (circulatory, dysmetabolic, post-traumatic and mixed);
- dysautonomia syndrome;
- mild cognitive disorders of atherosclerotic genesis;
- anxiety disorders in neurotic and neurosis-like states;
- coronary heart disease as part of complex therapy;
- relief of alcohol withdrawal syndrome with a predominance of neurosis-like and vegetative-vascular disorders, post-withdrawal disorders;
- condition after acute intoxication with antipsychotic drugs;
- asthenia and prevention of somatic diseases development under extreme factors and loads effect;
- extreme (stress) factors effect.
Shelf life: 2 years